View in browser

Header

Dear reader,

Postponed therapies, delayed diagnostics, discontinued long-term research: Covid-19 has put many processes on standby – with serious consequences. One year into the pandemic, we look at how experts from surgery to lab medicine are reshaping procedures to minimize the coronavirus collaterals – a task that is complicated further by the ongoing Brexit.

Enjoy reading!

Covid-19 collaterals

Coronavirus impacts heart surgery across Europe

Cardiac surgery across Europe is being set back as a result of the ongoing coronavirus. Operations are being postponed, treatment delayed, and critical care staff have been redeployed to cope with the impact of the Covid-19 epidemic on health...

Laboratory management

Covid-19: Overcoming unprecedented challenges

During a pandemic, the demands for laboratory testing challenge routines in an efficiently run clinical laboratory. Gold standard procedures may need modification, or to be discarded, and the more nimble, resilient and receptive a lab is to change,

Oncology expert debate

Post-Brexit and future cancer research: What EU/UK deals may mean

Despite Brexit uncertainties, four leading UK cancer research experts expressed optimism for continued pan-European collaboration and innovation during the online panel debate ‘Brexit deal: What it really means for cancer research and

Corona demographics

Why Covid-19 registries for cancer patients are so important

Due to compromised immune systems cancer patients are at higher risk of contracting infections. How does cancer impact on patients who also contract Covid-19? To collect this data, four cancer registries, one in the EU, one in the UK, two in the

Advancing diagnostic accuracy

PSMA PET/CT in prostate cancer evaluation

Hybrid PET/CT imaging can fully play to its strengths and steer treatment towards more effective procedures for diagnosing prostate cancer. The examination of the specific antigen PSMA with hybrid PET imaging enables treatment monitoring with

Earlier, better insights

New developments in whole-body MRI for prostate cancer

Whole-body magnetic resonance imaging (WB-MRI) can detect prostate cancer and inform about treatment response and disease progression earlier and better than other imaging modalities. A Belgian expert will delve into the latest and future

nothing to see here

 

You are receiving this email because you subscribed to our newsletter on healthcare-in-europe

If you don’t want to receive this newsletter anymore, click here to unsubscribe.

Keep up-to-date on the latest news from all hospital-related fields!
Subscribe to our bi-monthly newsletter.

Copyright © 2021 by European Hospital. All rights reserved.

EUROPEAN HOSPITAL Verlags GmbH
Theodor-Althoff-Str. 45, 45133 Essen, Germany

email: newsletter@european-hospital.com

Facebook
Twitter
RSS-Feed